2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1356861496 MD
Verify on CMS →

Javier Duron Tabora, MD

Endocrinology, Diabetes & Metabolism Physician in Sparta, New Jersey.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 488 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
42%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$3.4K
212 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Javier Duron Tabora, MD filed 3,202 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Sparta, New Jersey, prescribing 42% generic.

3K
Part D claims, 2024
42%
generic prescribing
Likely
board-certified (heuristic)
≥89th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Javier Duron Tabora, MD

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1356861496), first enumerated 06/20/2017.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 3,202 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $3.4K in reported industry payments (212 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1356861496 · Endocrinology, Diabetes & Metabolism Physician

NPI-10 · ENUM-RECENT · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1356861496
  • ENUM-RECENT 2017
  • TAX-MID 8K Endocrinology, Diabetes
  • RX-MID 3,202
  • BOOK-THIN 330 in New Jersey
  • PHOTO-ENUM Tien-Hao Lee · 2017

Javier Duron Tabora, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

3,202 ≥ 89th percentile 89% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). Below this entry. 800–1,000: 43,043 prescribers (3%). Below this entry. 1,000–1,200: 33,612 prescribers (2%). Below this entry. 1,200–1,400: 27,889 prescribers (2%). Below this entry. 1,400–1,600: 23,183 prescribers (2%). Below this entry. 1,600–1,800: 19,917 prescribers (1%). Below this entry. 1,800–2,000: 17,585 prescribers (1%). Below this entry. 2K+: 226,899 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Javier Duron Tabora, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Javier Duron Tabora, MD?

Quality data not reported

NPI registry status

Active

Issued 06/20/2017

NPI 1356861496

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

8,078 US NPIs in this specialty

Medicare Part D claims

3,202 17% vs specialty avg

2024 prescription claims

Specialty avg: 2,739

Specialty distribution in New Jersey

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers

New Jersey providers
Mental Health Counselor6.2%Physical Therapist5.8%Student in an Organized Heal…5.6%Clinical Social Worker5.5%Pharmacist5%Internal Medicine Physician3.1%Endocrinology, Diabetes & Me…0.2%
Largest specialties in New Jersey (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

89 SPARTA AVE STE 220
Sparta, NJ 07871

Provider Details

NPI 1356861496
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Male
NPI Issued 06/20/2017

Hospital and facility affiliations

Facilities where Javier Duron Tabora, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Practice Associates Medical Group
Sparta, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Javier Duron Tabora, MD. Source: openpaymentsdata.cms.gov.

Total received

$3.4K

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

Javier Duron Tabora, MD - brand share 52.0%
Endocrinology, Diabetes & Metabolism Physician average

52% brand-name claims vs 42% generic, on 3,202 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

3,202
Total Claims
$1.4M
Total Drug Cost
488
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,779.667
Total Day Supply
169,932
Brand vs Generic
52% brand / 42% generic
Brand Drug Cost
$1.4M
Generic Drug Cost
$26K

Patient Demographics

Average Patient Age
67.4 years
Avg HCC Risk Score
1.69
Gender Split
61% female / 39% male
Age Distribution
<65: 139, 65-74: 229, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Javier Duron Tabora, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Levothyroxine Sodium
345
Ozempic
Semaglutide
307
Jardiance
Empagliflozin
227
Lantus Solostar
Insulin Glargine,hum.Rec.Anlog
164
Atorvastatin Calcium
139
Metformin Hcl Er
Metformin Hcl
137
Metformin Hcl
123
Mounjaro
Tirzepatide
116
Synthroid
Levothyroxine Sodium
72
Glipizide Er
Glipizide
68

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Javier Duron Tabora, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider

Javier Duron Tabora, MD's 3,202 claims are above the specialty average of 2,739.

Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Duron Tabora, both outside New Jersey so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2017)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Duron Tabora.

One of 330 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New Jersey, 5 are shown here.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Javier Duron Tabora, MD's specialty?
Javier Duron Tabora, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Sparta, New Jersey. Credentials: MD.
How much does Javier Duron Tabora, MD prescribe under Medicare Part D?
In 2024, Javier Duron Tabora, MD wrote 3,202 Medicare Part D claims totaling $1.4M in drug costs for 488 beneficiaries.
Where is Javier Duron Tabora, MD located?
Javier Duron Tabora, MD is located at 89 SPARTA AVE STE 220, Sparta, NJ, 07871. Phone: (973) 512-5641.
What is Javier Duron Tabora, MD's NPI number?
Javier Duron Tabora, MD's National Provider Identifier (NPI) is 1356861496, issued on 06/20/2017.
Does Javier Duron Tabora, MD prescribe more brand-name or generic drugs?
Javier Duron Tabora, MD's prescribing is 52% brand-name and 42% generic drugs by claim count, with $1.4M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Javier Duron Tabora, MD prescribe most often?
Based on 2024 Medicare Part D data, Javier Duron Tabora, MD's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Javier Duron Tabora, MD accept Medicare?
Javier Duron Tabora, MD appears in CMS Medicare data with 3,202 Part D claims and 488 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Javier Duron Tabora, MD's credentials?
Javier Duron Tabora, MD's NPI is 1356861496 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.